MABVAX THERAPEUTICS HOLDINGS, INC. - FORM S-1/A - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - August 24, 2015

Attached files

file filename
S-1/A - S-1/A (AMENDMENT 2) - MABVAX THERAPEUTICS HOLDINGS, INC.mbvxs1a2_aug2015.htm
EX-1.1 - FORM OF UNDERWITING AGREEMENT - MABVAX THERAPEUTICS HOLDINGS, INC.ex1-1.htm
EX-10.37 - FORM OF PROPOSED LEASE AGREEMENT WITH AGP SORRENTO BUSINESS COMPLEX, L.P - MABVAX THERAPEUTICS HOLDINGS, INC.ex10-37.htm
EX-5.1 - OPINION OF SICHENZIA ROSS FRIEDMAN FERENCE LLP, AS TO THE LEGALITY OF THE SECURITIES BEING REGISTERED - MABVAX THERAPEUTICS HOLDINGS, INC.ex5-1.htm
EX-4.10 - FORM OF WARRANT AGENCY AGREEMENT BETWEEN MABVAX THERAPEUTICS HOLDINGS, INC. AND EQUITY STOCK TRANSFER LLC AND THE FORM OF WARRANT CERTIFICATE - MABVAX THERAPEUTICS HOLDINGS, INC.ex4-10.htm
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
 
We consent to the inclusion in this Registration Statement on Form S-1 (file No. 333-204803) of Mabvax Therapeutics Holdings, Inc. of our report, which includes an explanatory paragraph relating to MabVax Therapeutics Holdings, Inc.'s ability to continue as a going concern, dated March 31, 2015, related to our audits of the consolidated financial statements of MabVax Therapeutics Holdings, Inc. as of December 31, 2014 and 2013 and for the years then ended.  We also consent to the reference to our Firm under the caption “Experts”.

/s/ CohnReznick LLP

San Diego, California
August 19, 2015

Stock widget

Investing forum

MABVAX THERAPEUTICS HOLDINGS, INC. Reports

Also read